Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

Evaluate if addition and use of real time continuous glucose monitoring (RT-CGM) improves glycemic outcome of patients using multiple daily injections (MDI) and self monitoring blood glucose (SMBG) testing, who are not at target glycemic control.

Key facts

Study ID

NCT02282397

Run by

DexCom, Inc.

People needed

316

Starts

2014-09-01

Expected to finish

2016-11-01

Last updated by the study team

2017-05-15

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 25 years or older
• Diagnosis of Type 1 diabetes mellitus or insulin-requiring Type 2 diabetes mellitus
• Followed regularly by a physician or diabetes educator
• Using multiple daily injections
• stable control of diabetes
• willing to wear a device such as pump or continuous glucose monitor

You may not qualify if…

• recent or planned use of non-insulin injectable hypoglycemic agents
• Pregnancy or planning to become pregnant during the study
• Medical conditions that make it inappropriate or unsafe to target an A1C of <7%
• Renal disease with Glomerular Filtration Rate <45
• Extensive skin changes/disease that precludes wearing the sensor on normal skin
• Known allergy to medical-grade adhesives
• Recent hospitalization or emergency room visit in the 6 months prior to screening resulting in primary diagnosis of uncontrolled diabetes

Where it is running

• Marin Endocrine Care & Research — Greenbrae, California, United States
• Coastal Metabolic Research Centre — Ventura, California, United States
• East Coast Institute for Research, LLC — Jacksonville, Florida, United States
• East Coast Institute for Research, LLC — Jacksonville, Florida, United States
• Laureate Medical Group at Northside, LLC — Atlanta, Georgia, United States
• Atlanta Diabetes Associates — Atlanta, Georgia, United States
• Columbus Regional Research Institute — Columbus, Georgia, United States
• Physicians Research Associates, LLC — Lawrenceville, Georgia, United States
• Endocrine Research Solutions — Roswell, Georgia, United States
• Rocky Mountain Diabetes & Osteoporosis Center — Idaho Falls, Idaho, United States
• Iowa Diabetes & Endocrinology Research Center — Des Moines, Iowa, United States
• Joslin Diabetes Center — Boston, Massachusetts, United States
• Henry Ford Health System — Detroit, Michigan, United States
• International Diabetes Center — Minneapolis, Minnesota, United States
• Washington University in St. Louis — St Louis, Missouri, United States
• Diabetes & Endocrine Associates, PC — Omaha, Nebraska, United States
• Accent Clinical Research — Las Vegas, Nevada, United States
• Albany Medical College — Albany, New York, United States
• Mountain Diabetes and Endocrine Center — Asheville, North Carolina, United States
• Legacy Research Institute — Portland, Oregon, United States
• Oregon Health & Science University — Portland, Oregon, United States
• Amarillo Medical Specialists, LLP — Amarillo, Texas, United States
• Research Institute of Dallas — Dallas, Texas, United States
• Diabetes and Glandular Disease — San Antonio, Texas, United States
• Consano Clinical Research — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.